Current Biotechnology News

April 30, 2014
Current Projects and Student

Sensorion newest biotech IPO hitting ParisFinancing

By using new investor Forbion Capital Partners, UK-based biopharma Akarna Therapeutics has actually raised US$15m (€13.4m) in a string B funding to produce fatty-liver disease remedies on the basis of a FXR agonist.

Event Assessment

The effective use of electronic technology inside pharmaceutical and biotechnology industry ended up being the focus associated with 9th Berlin Conference on internet protocol address in lifestyle Sciences. According to the 100+ expert attendees, the potential of brand new technologies was raised through cooperation from it and life research experts.

R&D

The promise of microbiome while the basis of new treatments has actually caught the attention of several. Now, UNITED KINGDOM biotherapeutics maker 4D pharma plc has actually cushioned its microbiome pipeline aided by the purchase of Irish Tucana wellness.

Commercialisation

In the future, meds comes into play bundles wearing a distinctive barcode and an anti-tampering unit. These steps are included in the EU’s new legislation to safeguard against falsified drugs.

Medical Research

It is not yet obvious the reason why a man passed away during a first-in-man clinical trial in January. A preliminary report discovered a number of “major shortcomings” by responsible CRO Biotrial. However, all regulations were complied with.

M&A

After having dodged several takeover attempts by Monsanto a year ago, agrobusiness giant Syngenta has now agreed to be acquired by chemical business ChemChina. The Swiss organization also revealed intends to go public within many years.

Funding

Recently formed Medicxi Ventures, a life sciences-dedicated VC firm-based in London, Geneva and Jersey, has closed a €210m investment fund to reinvest in European early-stage possessions.

Research

Altering person DNA because of the efficient gene editing technique CRISPR/Cas9, specially germline improvements, had been very long considered a taboo. Now, however, British researchers have received formal endorsement to tinker with embryo DNA.

See also:
  • sunwayswimwear.com
Source: www.european-biotechnology-news.com
RELATED FACTS
Share this Post
Tweets